Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandro Cosconati

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Journal of Medicinal Chemistry|January 7, 2014
Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cellsSergio Valente, Yiwei Liu, Michael Schnekenburger, et al.
European Journal of Medicinal Chemistry|March 28, 2026
Targeting Staphylococcus aureus with potent de novo-designed proline-core short antimicrobial lipopeptidesAntonia D'Aniello, Veronica Folliero, Roberto Bello-Madruga, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Pyrrolyl Pyrazoles as Non-Diketo Acid Inhibitors of the HIV-1 Ribonuclease H Function of Reverse TranscriptaseAntonella Messore, Angela Corona, Valentina Noemi Madia, et al.
European Journal of Medicinal Chemistry|May 27, 2026
Corrigendum to "Targeting Staphylococcus aureus with potent de novo-designed proline-core short antimicrobial lipopeptides" [Eur. J. Med. Chem. 310 (2026) 118784]Antonia D'Aniello, Veronica Folliero, Roberto Bello-Madruga, et al.
Cancers|January 1, 2020
Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast CancerRosaria Benedetti, Carmela Dell'Aversana, Tommaso De Marchi, et al.
Oncotarget|May 26, 2016
Everolimus induces Met inactivation by disrupting the FKBP12/Met complexLucia Raimondo, Valentina D'Amato, Alberto Servetto, et al.
Journal of Medicinal Chemistry|May 12, 2015
N-Substituted Quinolinonyl Diketo Acid Derivatives as HIV Integrase Strand Transfer Inhibitors and Their Activity against RNase H Function of Reverse TranscriptaseLuca Pescatori, Mathieu Métifiot, Suhman Chung, et al.
Journal of Medicinal Chemistry|April 2, 2014
Basic quinolinonyl diketo acid derivatives as inhibitors of HIV integrase and their activity against RNase H function of reverse transcriptaseRoberta Costi, Mathieu Métifiot, Suhman Chung, et al.
European Journal of Medicinal Chemistry|September 30, 2024
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modificationAnna Maria Trotta, Vincenzo Mazzarella, Michele Roggia, et al.
European Journal of Medicinal Chemistry|July 25, 2024
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sitesAnna Maria Trotta, Stefano Tomassi, Gaetana Di Maiolo, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Journal of Medicinal Chemistry|January 7, 2014
Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cellsSergio Valente, Yiwei Liu, Michael Schnekenburger, et al.
European Journal of Medicinal Chemistry|March 28, 2026
Targeting Staphylococcus aureus with potent de novo-designed proline-core short antimicrobial lipopeptidesAntonia D'Aniello, Veronica Folliero, Roberto Bello-Madruga, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Pyrrolyl Pyrazoles as Non-Diketo Acid Inhibitors of the HIV-1 Ribonuclease H Function of Reverse TranscriptaseAntonella Messore, Angela Corona, Valentina Noemi Madia, et al.
European Journal of Medicinal Chemistry|May 27, 2026
Corrigendum to "Targeting Staphylococcus aureus with potent de novo-designed proline-core short antimicrobial lipopeptides" [Eur. J. Med. Chem. 310 (2026) 118784]Antonia D'Aniello, Veronica Folliero, Roberto Bello-Madruga, et al.
Cancers|January 1, 2020
Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast CancerRosaria Benedetti, Carmela Dell'Aversana, Tommaso De Marchi, et al.
Oncotarget|May 26, 2016
Everolimus induces Met inactivation by disrupting the FKBP12/Met complexLucia Raimondo, Valentina D'Amato, Alberto Servetto, et al.
Journal of Medicinal Chemistry|May 12, 2015
N-Substituted Quinolinonyl Diketo Acid Derivatives as HIV Integrase Strand Transfer Inhibitors and Their Activity against RNase H Function of Reverse TranscriptaseLuca Pescatori, Mathieu Métifiot, Suhman Chung, et al.
Journal of Medicinal Chemistry|April 2, 2014
Basic quinolinonyl diketo acid derivatives as inhibitors of HIV integrase and their activity against RNase H function of reverse transcriptaseRoberta Costi, Mathieu Métifiot, Suhman Chung, et al.
European Journal of Medicinal Chemistry|September 30, 2024
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modificationAnna Maria Trotta, Vincenzo Mazzarella, Michele Roggia, et al.
European Journal of Medicinal Chemistry|July 25, 2024
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sitesAnna Maria Trotta, Stefano Tomassi, Gaetana Di Maiolo, et al.
Pageof 15